# ScoreItem: DHEA-S - Mulheres (60-69 anos)

**ID:** `019bf31d-2ef0-722d-b4b2-179c0785a20e`
**FullName:** DHEA-S - Mulheres (60-69 anos) (Exames - Laboratoriais)
**Unit:** ¬µg/dL
**Gender:** female
**Age Min:** 60 anos
**Age Max:** 69 anos

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 9 artigos
- Avg Similarity: 0.687

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-722d-b4b2-179c0785a20e`.**

```json
{
  "score_item_id": "019bf31d-2ef0-722d-b4b2-179c0785a20e",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** DHEA-S - Mulheres (60-69 anos) (Exames - Laboratoriais)
**Unidade:** ¬µg/dL
**G√™nero:** female
**Faixa Et√°ria:** 60-69 anos

**30 chunks de 9 artigos (avg similarity: 0.687)**

### Chunk 1/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.738

Stanczyk FZ, Bairey Merz CN. DHEA-S levels and
cardiovascular disease mortality in postmenopausal women: Results from the National
Institutes of Health‚ÄìNational Heart, Lung, and Blood Institute (NHLBI)-sponsored Women‚Äôs
Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2010;95:4985‚Äì4992
204. Christiansen JJ, Andersen NH, S√∏rensen KE, Pedersen EM, Bennett P, Andersen M,
Christiansen JS, J√∏rgensen JO, Gravholt CH. Dehydroepiandrosterone substitution in
female adrenal failure: no impact on endothelial function and cardiovascular parameters
despite normalization of androgen status. Clin Endocrinol 2007;66:426‚Äì433
205. Panjari M, Bell RJ, Jane F, Adams J, Morrow C, Davis SR. The safety of 52 weeks of
oral DHEA therapy for postmenopausal women. Maturitas 2009;63:240‚Äì245
206. Cleary MP, Zisk JF. Anti-obesity effect of two different levels of
dehydroepiandrosterone in lean and obese middle-aged female Zucker rats. Int J Obes
1986;10:193‚Äì204
207.

---

### Chunk 2/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** results | **Similarity:** 0.717

was further supported by the results of Egger¬ís regression test.Discussionis meta-analysis of randomized controlled trials (RCTs) evaluated the eÔ¨Äects of dehydroepiandrosterone (DHEA) supplementation on testosterone and estradiol levels in postmenopausal women. Our analysis of 21 RCTs revealed that DHEA supplementation signiÔ¨Åcantly increased both testosterone and estradiol concentrations, although substantial heterogeneity was observed across the included trials.Our Ô¨Åndings indicate that DHEA is particularly eÔ¨Äec-tive in elevating testosterone levels when administered at dosages  50 mg/day. Additionally, a marked increase in estradiol levels was noted among participants aged  60 years receiving the same dosage. ese Ô¨Åndings 
Fig. 2 Forest plot of the randomized controlled trials investigating the eÔ¨Äect of dehydroepiandrosterone (DHEA) supplementation on serum estradiol concentrations

Page 9 of 13
Heetal. Diabetology & Metabolic Syndrome          (2025) 17:258 
Fig.

---

### Chunk 3/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.716

randomized clinical trials. Exp Gerontol. 2020;141: 111110. 41. Zhu Y, Qiu L, Jiang F, GƒÉman M-A, Abudoraehem OS, Okunade KS, et al. The eÔ¨Äect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: a dose-response and meta-analysis of randomized clinical trials. Steroids. 2021;173:108889. 42. Jamka K, Adamczuk P, Skowronska A, Bojar I, Raszewski G. Assess-ment of the eÔ¨Äect of estradiol on biochemical bone turnover markers among postmenopausal women. Ann Agric Environ Med. 2021;28(2):78¬ñ96. 43. Clark BJ, Prough RA, Klinge CM. Mechanisms of action of dehydroepi-androsterone. Vitam Horm. 2018;108:29¬ñ73. 44. Brzozowska M, Lewi≈Ñski A. Changes of androgens levels in meno-pausal women. Menopause Review/PrzeglƒÖd Menopauzalny. 2020;19(4):151¬ñ4. 45. Nair KS, Rizza RA, O¬íBrien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355(16):1647¬ñ59. 46. Villareal DT, Holloszy JO.

---

### Chunk 4/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** discussion | **Similarity:** 0.708

ffect of Dehydroepiandrosterone
on Muscle Strength and Physical Function in Older Adults: A Systematic Review. J Am
Geriatr Soc 2011;59:997‚Äì1002
75. Kritz-Silverstein D, von M√ºhlen D, Gail A. Laughlin GA, Bettencourt R. Effects of
dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA
and well-ness (DAWN) trial. J Am Geriat Soc 2008;56:1292‚Äì8
76. Panjari M, Bell RJ, Jane F, et al..A randomized trial of oral DHEA treatment for sexual
function, well-being, and menopausal symptoms in postmenopausal women with low libido. J
Sex Med 2009; 6: 2579‚Äì2590
77. Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and metaanalysis of
randomized placebo-controlled trials of DHEA treatment effects on quality of life in women
with adrenal insufficiency.
J Clin Endocrinol Metab 2009;94:3676‚Äì81
78. Labrie F, Archer D, Bouchard C, et al.

---

### Chunk 5/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.707

n in the analysis. However, the potential inÔ¨Çuence of such metabolic factors on DHEA supplementation outcomes could introduce bias. Despite this, sensitivity analyses indicated that no single study disproportionately aÔ¨Äected the overall results, supporting the robustness of our conclusions.Our review did not account for these metabolic and comorbidity-related factors, which future research should control for or report in detail to minimize bias. Additionally, sensitivity analyses addressing these vari-ables would be valuable in future meta-analyses.Conclusionis meta-analysis found that DHEA supplementation at doses of 50 mg/day or higher signiÔ¨Åcantly increased testosterone levels, and in participants aged 60 years or older, signiÔ¨Åcantly elevated estradiol levels.

---

### Chunk 6/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** results | **Similarity:** 0.702

y oÔ¨Äer estro-genic beneÔ¨Åts, such as improved bone health and pro-tection against bone loss [47]. ese results are further supported by other meta-analyses that reported similar hormonal increases following DHEA supplementation [40, 41].Our review also observed a signiÔ¨Åcant increase in tes-tosterone levels with DHEA supplementation admin-istered for  26 weeks. In line with this, the review conducted by Wierman etal. evaluated the eÔ¨Äect of DHEA over a long period in older women and found that both estradiol and testosterone levels signiÔ¨Åcantly increased [48]. A prospective clinical trial found that 50 mg/day of DHEA led to a higher estradiol concentra-tion and testosterone levels after 6 months of treatment. ese Ô¨Åndings highlight the dynamic, time-dependent hormonal response to DHEA supplementation.Biochemically, DHEA serves as a precursor to both estrogens and androgens.

---

### Chunk 7/30
**Article:** Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women (2025)
**Journal:** Clinical Endocrinology
**Section:** abstract | **Similarity:** 0.699

Diretriz cl√≠nica da Society for Endocrinology para avalia√ß√£o de excesso androg√™nico em mulheres. DHEA-S s√©rico √© a medida mais confi√°vel de produ√ß√£o adrenal de andr√≥genos, particularmente √∫til na transi√ß√£o perimenop√°usica. Aproximadamente 25% da produ√ß√£o androg√™nica ocorre nas adrenais em mulheres pr√©-menop√°usicas, aumentando para 100% na p√≥s-menopausa. Decl√≠nio de DHEA-S inicia aos 30 anos devido √† involu√ß√£o da zona reticular adrenal.

---

### Chunk 8/30
**Article:** Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in community-dwelling postmenopausal women (2021)
**Journal:** BMC Geriatrics
**Section:** results | **Similarity:** 0.697

andgaitspeed.Furtherresultsshowedthatpostmeno-pausalwomenwithsarcopeniaweremorelikelytohavehigherDHEAlevels.However,T2andE2werenotre-latedtomusclemass,gripstrengthorgaitspeed.TheseresultssuggestedthatthecirculatingsexhormonesDHEAwasabetterbiomarkerthanT2andE2formusclestrengthandgaitspeed,whichlikelyoccurredbecauseDHEAisaprecursorforsexsteroids.Threerea-sonsmaysupportthishypothesis.First,DHEAdoesnotbindtosexhormone-bindingglobulin(SHBG),whichsuggeststhatDHEAhasfreeaccesstotargetorganscomparedtoSHBG-boundE2andT2[24].Second,DHEAisanandrogenprehormoneproducedinthezonareticularisofthefemaleadrenalglandandovarianthecacells,anditactsasanupstreamprecursorofT2andE2inpostmenopausalwomen[25].DHEAinpostmeno-pausalwomenbecomesthepredominantsexhormoneinsteadofE2[26].CirculatingDHEAprovidessubstratesthatarerequiredforconversionintopotentandrogensandestrogensinperipheraltissues.SkeletalmusclesarecapableofsynthesizingandrogensandestrogensfromDHEA[27].Therefore,TandE2levelsinserumdonotrepresenttheconcen

---

### Chunk 9/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.696

o DHEA supplementation.Biochemically, DHEA serves as a precursor to both estrogens and androgens. Once converted to DHEA sulfate in the liver, it undergoes further enzymatic trans-formation in peripheral tissues, where it contributes to the synthesis of active estrogens and androgens, includ-ing estradiol and testosterone [6].It is important to note that elevated levels of estradiol can have adverse eÔ¨Äects, such as stimulating the endo-metrium [27]. Consequently, prolonged high estradiol levels may increase the risk of developing endometrial carcinoma [49]. erefore, it is crucial to use low doses of DHEA to raise estradiol levels without overstimulating the endometrium [50]. In our review, subgroup analysis based on DHEA dosage showed that doses of 50 mg/day or higher signiÔ¨Åcantly increased estradiol levels.

---

### Chunk 10/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.693

HEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): a dose-response meta-analysis of randomized controlled trials. Exp Gerontol. 2020;136:110949. 4. Mohamad N-V, Razali N-SC, Shamsuddin N-AM. Dehydroepiandros-terone and bone health: mechanisms and insights. Biomedicines. 2024;12(12):2780. 5. Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA. The regula-tion of steroid action by sulfation and desulfation. Endocr Rev. 2015;36(5):526¬ñ63. 6. Tang J, Chen L-R, Chen K-H. The utilization of dehydroepiandrosterone as a sexual hormone precursor in premenopausal and postmenopausal women: an overview. Pharmaceuticals. 2021;15(1):46. 7. Yang N-C, Jeng K-CG, Ho W-M, Chou S-J, Hu M-L. DHEA inhibits cell growth and induces apoptosis in BV-2 cells and the eÔ¨Äects are inversely associated with glucose concentration in the medium. J Steroid Biochem Mol Biol. 2000;75(2¬ñ3):159¬ñ66. 8. De Menezes KJ, Peixoto C, Nardi AE, Carta MG, Machado S, Veras AB.

---

### Chunk 11/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.691

dose dehydroepiandrosterone affects
behavior in hypopituitary androgen-deficient women: a placebocontrolled trial. J Clin
Endocrinol Metab 2002;87:2046
144. van Thiel SW, Romijn JA, Pereira AM, et al. Effects of dehydroepiandrostenedione,
superimposed on growth hormone substitution, on quality of life and insulin-like growth factor
I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-
over trial. J Clin Endocrinol Metab 2005;90:3295‚Äì303
145. Lovas K, Gebre-Medhin G, Trovik T, et al. Replacement of dehydroepiandrosterone in
adrenal failure: no benefit for subjective health status and sexuality in a 9-month randomized
parallel group clinical trial. J Clin Endocrinol Metab 2003;88:1112‚Äì8
146. Avis NE, Brockwell S, Randolph Jr JF, et al. Longitudinal changes in sexual functioning
as women transition through menopause: results from the Study of Women‚Äôs Health Across
the Nation. Menopause 2009;16:442‚Äì52
147.

---

### Chunk 12/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** results | **Similarity:** 0.691

Windahl SH, Wu J, et al. Dehydroepiandrosterone supplementation results in varying tissue-speciÔ¨Åc levels of dihydrotestosterone in male mice. Endocrinology. 2022;163(12):163. 12. Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, et al. Sex-speciÔ¨Åc eÔ¨Äects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: a pooled analysis of four clinical trials. Clin Endocrinol. 2019;90(2):293¬ñ300.

Page 12 of 13Heetal. Diabetology & Metabolic Syndrome          (2025) 17:258 
 13. Yuan H, Ou Q, Ma Y, Chen R, Wu H, Li F, et al. EÔ¨Éciency of DHEA on diminished ovarian reserve patients undergoing IVF-ET based on ultrasonography. Int J Clin Exp Med. 2016;9:14337¬ñ44. 14. ScheÔ¨Äers CS, Armstrong S, Cantineau AE, Farquhar C, Jordan V. Dehy-droepiandrosterone for women in the perior postmenopausal phase. Cochrane Datab Syst Rev. 2015(1). 15. McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM.

---

### Chunk 13/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.688

composition with metabolism and disease. J Nutr Health Aging 2005;9:408‚Äì419
86. Berkman LF, Seeman TE, Albert M et al. High, usual and impaired functioning in
community-dwelling older men and women: Findings from the MacArthur Foundation
Research Network on Successful Aging. 
J Clin Epidemiol 1993;46:1129‚Äì1140
87. Morrison MF, Katz IR, Parmelee P et al. 
Dehydroepiandrosterone sulfate (DHEA-S) and
psychiatric and laboratory measures of frailty in a residential care population. Am J Geriatr
Psychiatry 1998;6:277‚Äì284
88. Abbasi A, Duthie EH, Sheldahl L et al. Association of dehydroepiandrosterone sulfate,
body composition, and physical fitness in independent communitydwelling older men and
women. J Am Geriatr Soc 1998;46:263‚Äì273
89. Clarke BL, Ebeling PR, Jones JD, Wahner HW, O‚ÄôFallon WM, Riggs BL, Fitzpatrick LA.
Predictors of bone mineraldensity in aging healthy men varies by skeletal site. Calcified Tiss
Int 2002;70:137‚Äì145
90.

---

### Chunk 14/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** conclusion | **Similarity:** 0.686

(WMD: 8.92 pg/mL), although the diÔ¨Äerences were modest and 95% CIs overlapped. For testosterone, higher levels were observed with DHEA dosages ‚â• 50 mg/day (WMD: 29.65 ng/dL).Conclusion DHEA supplementation at doses ‚â• 50 mg/day signiÔ¨Åcantly increases testosterone levels in postmeno-pausal women. Moreover, in women aged ‚â• 60 years, supplementation at the same dosage signiÔ¨Åcantly elevates estradiol levels.Keywords Dehydroepiandrosterone, Nutrition, Testosterone, Estradiol, Supplementation, Postmenopausal women
Open Access¬© The Author(s) 2025. Open Access  This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modiÔ¨Åed the licensed material.

---

### Chunk 15/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** other | **Similarity:** 0.683

verted into its sulfated form, DHEA sulfate (DHEA-S), which circulates at much higher concentrations and can be further metabolized into active sex hormones as needed [5].DHEA levels decline signiÔ¨Åcantly with age, decreasing by approximately 70% between the ages of 20 and 60, pri-marily due to reduced adrenal production. DHEA sup-plementation has been explored as an adjunct therapy for postmenopausal women, alongside hormone replace-ment therapy (HRT), and has demonstrated potential beneÔ¨Åts in improving metabolic and endocrine function, as well as sexual health [6]. DHEA exerts androgenic, estrogenic, and steroidal eÔ¨Äects and has been associated with various biological functions, including antioxidant properties, neuroprotection, and anticancer activity [7].

---

### Chunk 16/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** results | **Similarity:** 0.683

208
]. In humans studies, however, the results  are
rather inconsistent. In some studies, the lower levels of DHEA seen with aging have been
associated with impaired glucose tolerance, insulin resistance and diabetes [
212
-
215
], while
in another [
216
] exactly the opposite relation was shown as higher levels of DHEA were
13

associated with impaired glucose tolerance and diabetes mellitus in post-menopausal
women. The truth regarding DHEA/DHEAS and insulin resistance and its associated
conditions gets even more complicated considering conflicting results from interventional
studies with DHEA replacement. Thus, an ameliorating effect of long-term treatment with
DHEA on insulin resistance was described in a group of middle-aged hypo-adrenal women
treated with DHEA [
217
], but also in groups of elderly men [
97
] and postmenopausal women
[
97,217-220
] replaced with DHEA.

---

### Chunk 17/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** other | **Similarity:** 0.682

igher risk of osteopenia and osteoporosis in postmen-opausal women[42].Preclinical studies suggest that DHEA exerts tissue-speciÔ¨Åc eÔ¨Äects and acts by binding to estrogen and androgen receptors on cell membranes [43]. e primary beneÔ¨Åt of DHEA supplementation in postmenopausal women is its potential to raise estrogen levels to physio-logically functional ranges, thereby mimicking the eÔ¨Äects of endogenous estrogen [22]. DHEA serves as a precur-sor for nearly all circulating estrogens and androgens in postmenopausal women [44].Our Ô¨Åndings align with previous research indicating that a 50 mg/day dose of DHEA signiÔ¨Åcantly elevates both testosterone and estradiol levels [45¬ñ47]. A narra-tive review reported that supplementation with 50 mg of DHEA led to peak estradiol levels that may oÔ¨Äer estro-genic beneÔ¨Åts, such as improved bone health and pro-tection against bone loss [47].

---

### Chunk 18/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.681

ement
in healthy men with age-related decline of DHEA-S: Effects on fat distribution, insulin
sensitivity and lipid metabolism. Aging Male 2003; 6:151‚Äì156
27

108. Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio
B. Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on
body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol
Metab 2001;86:1968‚Äì 1972
109. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G.
Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab
1999;84:1527‚Äì1533
110. Percheron G, Hogrel JY, Denot-Ledunois S, Fayet G, Forette F, Baulieu EE, Fardeau
M, Marini JF. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-
year-old individuals on muscle function and cross-sectional area: A double-blind placebo-
controlled trial. Arch Int Med 2003;163:720‚Äì727
111.

---

### Chunk 19/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** results | **Similarity:** 0.680

sely associated with glucose concentration in the medium. J Steroid Biochem Mol Biol. 2000;75(2¬ñ3):159¬ñ66. 8. De Menezes KJ, Peixoto C, Nardi AE, Carta MG, Machado S, Veras AB. Dehydroepiandrosterone, its sulfate and cognitive functions. Clin Pract Epidemiol Ment Health CP EMH. 2016;12:24. 9. Ma Y, Fan X, Han J, Cheng Y, Zhao J, Fang W, et al. Critical illness and sex hormones: response and impact of the hypothalamic¬ñpituitary¬ñgonadal axis. Therap Adv Endocrinol Metab. 2025;16:20420188251328190. 10. Kawakita T, Yasui T, Yoshida K, Matsui S, Iwasa T. Correlations of andros-tenediol with reproductive hormones and cortisol according to stages during the menopausal transition in Japanese women. J Steroid Biochem Mol Biol. 2021;214: 106009. 11. Colld√©n H, Nilsson ME, Norl√©n A-K, Landin A, Windahl SH, Wu J, et al. Dehydroepiandrosterone supplementation results in varying tissue-speciÔ¨Åc levels of dihydrotestosterone in male mice. Endocrinology. 2022;163(12):163. 12.

---

### Chunk 20/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.678

onsidered when prescribing DHEA.Strength andlimitationsis meta-analysis provides a comprehensive overview and high-quality evidence on the eÔ¨Äects of DHEA sup-plementation on testosterone and estradiol levels in post-menopausal women. Importantly, no evidence of bias was detected.Nonetheless, our review has some limitations. e par-ticipants in the included randomized controlled trials (RCTs) represented a heterogeneous population, includ-ing healthy postmenopausal women, those with primary Sj√∂gren¬ís syndrome, and individuals with mild to mod-erate cognitive impairment. is diversity may limit the generalizability of our Ô¨Åndings. Additionally, signiÔ¨Åcant heterogeneity was observed across studies, warranting cautious interpretation of the results.

---

### Chunk 21/30
**Article:** Serum levels of dehydroepiandrosterone sulfate are associated with a lower risk of mobility-subtype frailty in older Japanese community-dwellers (2022)
**Journal:** Archives of Gerontology and Geriatrics
**Section:** abstract | **Similarity:** 0.676

Estudo prospectivo com 1.886 idosos da comunidade (60-91 anos) demonstrou que n√≠veis s√©ricos mais elevados de DHEA-S foram associados a menor risco de fragilidade, especialmente fragilidade do subtipo mobilidade. A an√°lise de medidas repetidas confirmou que a manuten√ß√£o de n√≠veis adequados de DHEA-S ao longo do tempo est√° inversamente relacionada ao desenvolvimento de fragilidade em idosos vivendo na comunidade, sugerindo papel protetor deste horm√¥nio na preserva√ß√£o da fun√ß√£o f√≠sica.

---

### Chunk 22/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.672

late postmenopause. Gynecolog Endocrinol 2000;14:342‚Äì363
139. Panjari M, Davis SR. DHEA therapy for women: effect on sexual function andwellbeing.
Human Reprod Update 2007;13:239‚Äì48 
140. Arlt W, Callies F, van Vlijmen JC, et al.. Dehydroepiandrosterone replacement in
women with adrenal insufficiency. N Engl J Med 1999; 341: 1013‚Äì1020
141. Mortola JF, Yen SS.The effects of oral dehydroepiandrosterone on endocrine-metabolic
parameters in postmenopausal women. J Clin Endocrinol Metab 1990; 71: 696‚Äì704
142. Wolf OT, Neumann O, Hellhammer DH, et al..Effects of a two-week physiological
dehydroepiandrosterone substitution on cognitive performance and well-being in healthy
elderly women and men. J Clin Endocrinol Metab 1997; 82: 2363‚Äì2367
143. Johannsson G, Burman P, Wiren L, et al. Low dose dehydroepiandrosterone affects
behavior in hypopituitary androgen-deficient women: a placebocontrolled trial. J Clin
Endocrinol Metab 2002;87:2046
144.

---

### Chunk 23/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 01 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.672

reavaliar a cada 6‚Äì8 semanas, checar SHBG, estradiol, DHT se pertinente) para padronizar seguimento.
### 8. DHEA (prasterona): papel, prescri√ß√£o e diferen√ßas entre sexos
- DHEA/DHEA-S: pr√≥-horm√¥nio, n√£o considerado horm√¥nio pleno; decl√≠nio com a idade, especialmente adrenal.
- Em mulheres, pode estimular horm√¥nios subsequentes; em homens, n√£o costuma ter fun√ß√£o robusta para estimular outros horm√¥nios.
- No Brasil, prescri√ß√£o como prasterona; estudos principalmente com comprimido; creme seria mais fisiol√≥gico, por√©m menos estudado; ambas formas poss√≠veis.
- Doses mulheres: baixas (10‚Äì15 mg) e monitorar porque pode elevar horm√¥nios indesejados; utilidade em infertilidade/autoimunes com dose b√°sica.
- Conceito de ‚Äúdesgaste‚Äù glandular ao longo da vida aplic√°vel √†s adrenais.
> **Sugest√µes de IA**
> - Organiza√ß√£o: Voc√™ delimitou bem diferen√ßas por sexo; inclua crit√©rios claros de quando considerar prasterona (indica√ß√µes vs quando evitar).

---

### Chunk 24/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** methods | **Similarity:** 0.670

lementation.Methods A comprehensive literature search was conducted across PubMed/Medline, Embase, Web of Science, and Scopus to identify relevant studies published before June 11, 2024. Data were analyzed using a random-eÔ¨Äects model and presented as weighted mean diÔ¨Äerences (WMDs) with 95% conÔ¨Ådence intervals (CIs).Results The analysis included 21 studies, comprising 17 trial arms assessing estradiol and 20 assessing testosterone. DHEA supplementation signiÔ¨Åcantly increased estradiol (WMD: 7.86 pg/mL; 95% CI 6.33¬ñ9.40; P ‚â§ 0.001) and tes-tosterone levels (WMD: 24.31 ng/dL; 95% CI 15.22¬ñ33.40; P ‚â§ 0.001). Subgroup analyses showed greater increases in estradiol levels among studies using DHEA dosages ‚â• 50 mg/day (WMD: 8.65 pg/mL) and those with participants aged ‚â• 60 years (WMD: 8.92 pg/mL), although the diÔ¨Äerences were modest and 95% CIs overlapped.

---

### Chunk 25/30
**Article:** Impact of DHEA supplementation on testosterone and estradiol levels in postmenopausal women: a meta-analysis of randomized controlled trials assessing dose and duration effects (2025)
**Journal:** Diabetology & Metabolic Syndrome
**Section:** discussion | **Similarity:** 0.669

ials investigating the eÔ¨Äect of dehydroepiandrosterone (DHEA) supplementation on serum estradiol concentrations

Page 9 of 13
Heetal. Diabetology & Metabolic Syndrome          (2025) 17:258 
Fig. 3 Forest plot of the randomized controlled trials investigating the eÔ¨Äect of dehydroepiandrosterone (DHEA) supplementation on serum testosterone concentrations
Fig. 4 Funnel plot of the weighted mean diÔ¨Äerence (WMD) versus the standard error (s.e.) of the WMD

Page 10 of 13Heetal. Diabetology & Metabolic Syndrome          (2025) 17:258 
are consistent with a previous meta-analysis by Li etal., which reported increased testosterone levels in partici-pants receiving > 50 mg/day of DHEA for  12 weeks, particularly among those under 60 years of age [40]. Sim-ilarly, Zhu etal. found that estradiol concentrations were signiÔ¨Åcantly increased in participants aged  60 years who received  50 mg/day of DHEA for  26 weeks [41].

---

### Chunk 26/30
**Article:** Dehydroepiandrosterone and Bone Health: Mechanisms and Insights (2024)
**Journal:** Nutrients
**Section:** abstract | **Similarity:** 0.668

Revis√£o recente (2024) sobre DHEA e sa√∫de √≥ssea. Em indiv√≠duos idosos com baixos n√≠veis de andr√≥genos, a suplementa√ß√£o de DHEA melhora a densidade mineral √≥ssea, particularmente no colo femoral de homens. O DHEA atua como modulador da sa√∫de √≥ssea atrav√©s de m√∫ltiplos mecanismos incluindo convers√£o em esteroides sexuais ativos. Entretanto, os autores ressaltam que ensaios cl√≠nicos abrangentes s√£o necess√°rios para avaliar sua efic√°cia e seguran√ßa, particularmente em popula√ß√µes de risco. Os efeitos s√£o sexo-espec√≠ficos, com benef√≠cios √≥sseos mais consistentes em mulheres do que em homens.

---

### Chunk 27/30
**Article:** Should Dehydroepiandrosterone Be Administered to Women? (2022)
**Journal:** The Journal of Clinical Endocrinology and Metabolism
**Section:** abstract | **Similarity:** 0.667

Revis√£o cr√≠tica sobre administra√ß√£o de DHEA em mulheres. Evid√™ncias suportam pequenos benef√≠cios na qualidade de vida e humor em mulheres com insufici√™ncia adrenal prim√°ria/secund√°ria ou anorexia, mas n√£o para ansiedade ou fun√ß√£o sexual. O efeito √≥sseo de DHEA √© significativamente menor que terapia estrog√™nica ou medica√ß√µes aprovadas para osteoporose. DHEA vaginal local mostra promessa para atrofia vulvovaginal.

---

### Chunk 28/30
**Article:** Adrenal Androgens and Aging (2023)
**Journal:** Endotext
**Section:** other | **Similarity:** 0.667

men. Age Ageing 2009;38:401‚Äì406
70. Baulieu E, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate,
and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Nat Acad Natl
Sci 2000;97:4279‚Äì84
71. Ohlsson C, Labrie F, Barrett-Connor E, Karlsson MK, Ljunggren O, et al. Low serum
levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in
elderly Swedish men. J Clin Endocrinol Metab 2010; 95: 4406‚Äì4414
72. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF (1999) DHEA and DHEA-S: a
review. 
J Clin Pharmacol 39: 327‚Äì348
73. Nair KS, Rizza RA, O‚ÄôBrien P, et al. 
DHEA in elderly women and DHEA or testosterone
in elderly men. N Engl J Med 2006;355:1647‚Äì1659
74. William L. Baker, Shobha Karan, and Anne M. Kenny Effect of Dehydroepiandrosterone
on Muscle Strength and Physical Function in Older Adults: A Systematic Review. J Am
Geriatr Soc 2011;59:997‚Äì1002
75. Kritz-Silverstein D, von M√ºhlen D, Gail A.

---

### Chunk 29/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 01 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.665

80 anos com testosterona de 500-600, sugerindo que seus n√≠veis de pico na juventude poderiam ter sido muito mais altos (ex: 1.500).
*   **Decl√≠nio Hormonal Feminino e DHEA**
    - Mulheres tamb√©m experimentam um decl√≠nio na testosterona, que √© produzida pelos ov√°rios e adrenais. A queda pode ser menos linear que nos homens, pois a produ√ß√£o adrenal pode ser preservada.
    - O DHEA (deidroepiandrosterona), um pr√≥-horm√¥nio precursor, diminui nitidamente com a idade, indicando um "desgaste" da gl√¢ndula adrenal.
    - A prescri√ß√£o de DHEA (prasterona no Brasil) √© feita em comprimidos (forma mais estudada) ou creme (forma mais fisiol√≥gica). Doses para mulheres s√£o menores (10-15mg) para evitar convers√µes indesejadas. Para homens, sua fun√ß√£o como estimulador de outros horm√¥nios √© menos estabelecida.
### 4.

---

### Chunk 30/30
**Article:** Ritmo Circadiano Eixo HPA - Parte XI (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.663

omens, a dose m√©dia de DHEA varia entre 25 e 50 miligramas.
- Notavelmente, uma dose de 50 mg de DHEA, geralmente associada a homens, tamb√©m √© indicada para mulheres com o objetivo de melhorar o humor, o bem-estar e a fun√ß√£o sexual.
**A S√≠ndrome da Fadiga Cr√¥nica (SFC) afeta predominantemente adultos jovens entre 20 e 40 anos, com uma preval√™ncia duas a tr√™s vezes maior em mulheres do que em homens.**
- A SFC √© mais comum em adultos na faixa et√°ria de 20 a 40 anos.
- As mulheres s√£o diagnosticadas com SFC de duas a tr√™s vezes mais frequentemente do que os homens, indicando uma clara disparidade de g√™nero na preval√™ncia da condi√ß√£o.
### Achados Adicionais Chave
- A ideia de que as gl√¢ndulas adrenais s√£o as primeiras a mostrar sinais de cansa√ßo foi introduzida em uma publica√ß√£o de 1921.

---

